Mattias Levin, PhD, Senior Team Manager, Antibody Engineering, at Alligator Bioscience, will give a presentation entitled "Neo-X-Prime™: Bispecific Tumor Antigen Conditional CD40 Agonistic Antibodies" at 5:00 pm CET on November 3.
Malin Lindstedt, visiting professor at Alligator Bioscience and Professor at the Department of Immunotechnology at Lund University, will give a poster presentation entitled “Early pharmacodynamic changes measured by RNA sequencing in peripheral blood from patients in a phase 1 study with mitazalimab, a potent CD40 agonistic IgG1 monoclonal antibody”, poster number 35, on November 10. […]
Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.
Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will give a corporate presentation followed by a Q&A session at 1:00 pm CET on November 30.
We use cookies for administering, monitoring and optimizing the website, and for analytical purposes, in accordance with what is stated in our
cookie policy.